title: Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma.
abstract: Cholangiocarcinoma (CCA) is a fatal cancer of the biliary epithelium, arising either within the liver (intrahepatic, ICC) or in the extrahepatic bile ducts (extrahepatic ECC). Globally, CCA is the second most common primary hepatic malignancy. Several recent epidemiological studies have shown that the incidence and mortality rates of ICC are increasing. This review of the literature on the international epidemiological rates of CCA, both intra- and extrahepatic, explores possible explanations for the trends found. The possible role of epidemiological artifact in the findings is discussed and the known risk factors for CCA are summarized. These include primary sclerosing cholangitis, liver fluke infestation, congenital fibropolycystic liver, bile duct adenomas, and biliary papillomatosis, hepatolithiasis, chemical carcinogens such as nitrosamines, Thorotrast, chronic viral hepatitis, cirrhosis, chronic non-alcoholic liver disease and obesity. Potential pathways involved in the molecular pathogenesis of CCA are also summarized.
authors.affiliation: Department of Hepatology and Gastroenterology, Imperial College London, London, UK. shahid.khan@imperial.ac.uk
authors.forename: S A
authors.initials: SA
authors.lastname: Khan
authors.forename: M B
authors.initials: MB
authors.lastname: Toledano
authors.forename: S D
authors.initials: SD
authors.lastname: Taylor-Robinson
references.citation: Br J Surg. 2002 Aug;89(8):962-70
references.pmid: 12153620
references.citation: Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8
references.pmid: 17689296
references.citation: Gut. 2003 Apr;52(4):586-91
references.pmid: 12631674
references.citation: BMC Cancer. 2002 May 03;2:10
references.pmid: 11991810
references.citation: Hepatology. 2001 Jun;33(6):1353-7
references.pmid: 11391522
references.citation: Cancer. 2000 Jun 1;88(11):2471-7
references.pmid: 10861422
references.citation: Int J Epidemiol. 1996 Oct;25(5):933-40
references.pmid: 8921477
references.citation: Hepatology. 1998 Oct;28(4):921-5
references.pmid: 9755226
references.citation: Am J Gastroenterol. 2007 May;102(5):1016-21
references.pmid: 17324130
references.citation: Lancet. 2005 Oct 8;366(9493):1303-14
references.pmid: 16214602
references.citation: Abdom Imaging. 2003 Jan-Feb;28(1):72-4
references.pmid: 12483389
references.citation: J Hepatol. 2006 Dec;45(6):856-67
references.pmid: 17030071
references.citation: Br J Cancer. 1984 Sep;50(3):389-97
references.pmid: 6087869
references.citation: Int J Cancer. 2007 Feb 1;120(3):638-41
references.pmid: 17109384
references.citation: Gastroenterology. 2005 Mar;128(3):620-6
references.pmid: 15765398
references.citation: J Hepatol. 2004 Mar;40(3):472-7
references.pmid: 15123362
references.citation: J Gastroenterol Hepatol. 2002 Oct;17(10):1049-55
references.pmid: 12201863
references.citation: J Gastroenterol Hepatol. 1999 Dec;14(12):1144-9
references.pmid: 10634149
references.citation: J Natl Cancer Inst. 2006 Jun 21;98(12):873-5
references.pmid: 16788161
references.citation: Semin Liver Dis. 2004 May;24(2):127-37
references.pmid: 15192786
references.citation: Cancer Causes Control. 2001 Dec;12(10):959-64
references.pmid: 11808716
references.citation: World J Surg. 1995 Jul-Aug;19(4):637-41
references.pmid: 7676713
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203
references.pmid: 16775181
references.citation: Br J Cancer. 2006 Jun 5;94(11):1751-8
references.pmid: 16736026
references.citation: J Natl Cancer Inst. 2007 Jun 6;99(11):895-7
references.pmid: 17551150
references.citation: Semin Liver Dis. 2004 May;24(2):115-25
references.pmid: 15192785
references.citation: Cancer Res. 1978 Dec;38(12):4634-9
references.pmid: 214229
references.citation: J Hepatol. 2002 Dec;37(6):806-13
references.pmid: 12445422
references.citation: Gut. 2001 Jun;48(6):816-20
references.pmid: 11358902